How much is Neurotologix worth in 2026?

Neurotologix has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Neurotologix raised?

Neurotologix has raised N/A in total funding across 1 funding rounds.

Neurotologix

Diagnostic Equipment

Neurotologix valuation and funding history | Last updated: July 16, 2021 | 1 funding rounds

Current Valuation

N/A

As of July 16, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Jul 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 16, 2021	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Neurotologix is currently valued at N/A as of July 16, 2021.

Track Neurotologix Valuation Updates

Get notified when Neurotologix raises new funding or valuation changes

Explore More Data

Detailed analysis for Neurotologix

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Neurotologix's valuation history, funding rounds, and growth metrics.

No credit card required

What is Neurotologix Worth in 2026?

Neurotologix is a leading private company in the Diagnostic Equipment sector. Track Neurotologix's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Neurotologix Valuation is Determined

Private company valuations like Neurotologix's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.